Shopping Cart
Remove All
Your shopping cart is currently empty
CXJ-2, a cyclic peptide, demonstrates moderate affinity for elastin-derived peptides (EDPs) and exhibits potent inhibition of the PI3K/ERK pathway, alongside significant reduction in hepatic stellate cell proliferation and migration, conferring strong antifibrotic efficacy [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | CXJ-2, a cyclic peptide, demonstrates moderate affinity for elastin-derived peptides (EDPs) and exhibits potent inhibition of the PI3K/ERK pathway, alongside significant reduction in hepatic stellate cell proliferation and migration, conferring strong antifibrotic efficacy [1]. |
| In vitro | CXJ-2, at a concentration of 10 μM incubated for 24 hours, demonstrated dose-dependent inhibition of α-SMA expression in LX2 cells [1]. Additionally, CXJ-2 showed significant activity in suppressing the proliferation of LX2 cells under the same conditions [1]. |
| In vivo | CXJ-2, administered intraperitoneally at a dosage of 150 μg/kg daily for three weeks, significantly alleviates liver fibrosis in mice [1]. Additionally, a single subcutaneous injection of CXJ-2 at 0.1 mg/kg exhibits favorable pharmacokinetic properties [1]. |
| Molecular Weight | 1310.37 |
| Formula | C55H87N15O22 |
| Cas No. | 2919976-92-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.